<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (IDENTIFY SPECIFIC FINANCIAL STATEMENTS HERE) THE COMPANY'S CONSOLIDATED INCOME STATEMENT, CONSOLIDATED BALANCE SHEET, AND CONSOLIDATED STATEMENT OF CASH FLOWS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000815094 <NAME> ABIOMED, INC. <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> MAR-31-2000 <PERIOD-START> APR-01-1999 <PERIOD-END> SEP-30-1999 <CASH> 5,117,314 <SECURITIES> 8,543,274 <RECEIVABLES> 7,126,081 <ALLOWANCES> 209,701 <INVENTORY> 3,559,112 <CURRENT-ASSETS> 24,714,854 <PP&E> 8,917,312 <DEPRECIATION> 5,109,700 <TOTAL-ASSETS> 29,658,800 <CURRENT-LIABILITIES> 6,167,909 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 86,577 <OTHER-SE> 23,245,539 <TOTAL-LIABILITY-AND-EQUITY> 29,658,800 <SALES> 10,519,990 <TOTAL-REVENUES> 10,519,990 <CGS> 9,314,614 <TOTAL-COSTS> 14,724,614 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> (397,503) <INCOME-PRETAX> (3,807,121) <INCOME-TAX> 0 <INCOME-CONTINUING> (3,807,121) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (3,807,121) <EPS-BASIC> (.44) <EPS-DILUTED> (.44)